CREB1 and Alzheimer disease: In this connection, characterizing the N-[2-(3, 4-dimethoxyphenyl) ethyl]-3-phenyl-acrylamide (gx-50) compound as a novel neuroprotective agent, Tang and collaborators further proved the involvement of glycogen synthase kinase-3 (GSK-3)/CREB pathway in AD.